Molecule.one grows its drug synthesis AI platform with a $4.6M seed round
TechCrunch
JUNE 1, 2021
Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. The company leverages machine learning and a large body of knowledge about chemical reactions to create these processes, though as CSO Stanis? . odarczyk-Pruszy?ski
Let's personalize your content